Fulgent Genetics Ownership | Who Owns Fulgent Genetics?


OverviewForecastRevenueFinancialsChartTranscripts

Fulgent Genetics Ownership Summary


Fulgent Genetics is owned by 56.12% institutional investors, 36.64% insiders, and 7.24% retail investors. Blackrock is the largest institutional shareholder, holding 13.17% of FLGT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.19% of its assets in Fulgent Genetics shares.

FLGT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockFulgent Genetics56.12%36.64%7.24%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryDiagnostics & Research Stocks50.92%10.77%38.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock3.92M13.17%$76.93M
Blackrock funding, inc. /de2.77M9.01%$44.11M
Rtw investments, lp1.29M4.19%$20.50M
Vanguard group1.26M4.10%$33.10M
Acadian asset management1.23M4.01%$19.60M
Dimensional fund advisors lp671.66K2.18%$10.68M
Invenomic capital management lp610.32K1.98%$9.70M
Geode capital management584.21K1.90%$9.29M
Ameriprise financial563.38K1.83%$8.96M
State street529.40K1.72%$8.42M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Peapod lane capital220.63K2.86%$3.49M
Diametric capital, lp361.05K1.49%$5.74M
Medina value partners170.07K0.57%$2.70M
Invenomic capital management lp610.32K0.45%$9.70M
Almitas capital104.80K0.38%$1.67M
Rtw investments, lp1.29M0.20%$20.50M
Portolan capital management106.64K0.09%$1.70M
Counterpoint mutual funds34.31K0.08%$545.47K
Entrypoint capital15.74K0.07%$250.35K
Prelude capital management56.31K0.07%$895.31K

Top Buyers

HolderShares% AssetsChange
Invenomic capital management lp610.32K0.45%610.32K
Rtw investments, lp1.29M0.20%583.97K
Jacobs levy equity management356.36K0.02%356.36K
Jpmorgan chase460.36K0.00%210.24K
Medina value partners170.07K0.57%170.07K

Top Sellers

HolderShares% AssetsChange
Millennium management401.82K0.00%-537.56K
Divisadero street capital management, lp---505.21K
Park west asset management---447.94K
Qube research---286.51K
Point72 asset management---236.95K

New Positions

HolderShares% AssetsChangeValue
Invenomic capital management lp610.32K0.45%610.32K$9.70M
Jacobs levy equity management356.36K0.02%356.36K$5.67M
Medina value partners170.07K0.57%170.07K$2.70M
Vanguard fiduciary trust129.47K0.00%129.47K$2.06M
Norges bank85.36K0.00%85.36K$1.67M

Sold Out

HolderChange
Mendota financial group-1.00
True wealth design-2.00
Nelson, van denburg & campbell wealth management group-4.00
Kilter group-4.00
Pfg private wealth management-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026155-15.30%17,270,541-3.26%561.66%74-14.94%52-5.45%
Dec 31, 202579-52.98%5,727,637-66.75%180.60%39-48.68%19-64.15%
Sep 30, 202560-64.71%2,512,365-84.55%80.29%22-71.79%16-69.23%
Jun 30, 2025170-4.49%16,263,044-0.16%521.89%79-4.82%51-3.77%
Mar 31, 2025177-8.29%16,286,336-4.40%521.68%83-18.63%538.16%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.29M4.19%-333.00
Vanguard Total Stock Mkt Idx Inv624.74K2.10%-
Vanguard US Total Market Shares ETF604.63K1.96%-
iShares Russell 2000 ETF486.77K1.71%4.09K
Columbia Small Cap Value Discv A372.38K1.31%-
Columbia Small Cap Value Discovery Fund372.38K1.29%16.80K
Columbia Small Cap Value I A347.08K1.13%9.50K
Columbia Small Cap Value I337.58K1.11%-87.12K
BlackRock Advantage Small Cap Core Instl306.17K1.03%-
Xtrackers MSCI World Swap ETF 1C302.77K0.98%-1.91K

Recent Insider Transactions


DateNameRoleActivityValue
May 27, 2026Xie Jian President and COOSell$21.14K
May 27, 2026Gao Hanlin Chief Scientific OfficerSell$16.63K
Dec 02, 2025Xie Jian President and COOSell$32.30K
Dec 02, 2025Gao Hanlin Chief Scientific OfficerSell$30.46K
Nov 28, 2025Xie Jian President and COOSell$35.42K

Insider Transactions Trends


DateBuySell
2026 Q2-2
2026 Q1--
2025 Q4-7
2025 Q3-6
2025 Q2-6

FLGT Ownership FAQ


Who Owns Fulgent Genetics?

Fulgent Genetics shareholders are primarily institutional investors at 56.12%, followed by 36.64% insiders and 7.24% retail investors. The average institutional ownership in Fulgent Genetics's industry, Diagnostics & Research Stocks, is 50.92%, which Fulgent Genetics exceeds.

Who owns the most shares of Fulgent Genetics?

Fulgent Genetics’s largest shareholders are Blackrock (3.92M shares, 13.17%), Blackrock funding, inc. /de (2.77M shares, 9.01%), and Rtw investments, lp (1.29M shares, 4.19%). Together, they hold 26.37% of Fulgent Genetics’s total shares outstanding.

Does Blackrock own Fulgent Genetics?

Yes, BlackRock owns 13.17% of Fulgent Genetics, totaling 3.92M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 76.93M$. In the last quarter, BlackRock increased its holdings by 547 shares, a 0.01% change.

Who is Fulgent Genetics’s biggest shareholder by percentage of total assets invested?

Peapod lane capital is Fulgent Genetics’s biggest shareholder by percentage of total assets invested, with 2.86% of its assets in 220.63K Fulgent Genetics shares, valued at 3.49M$.

Who is the top mutual fund holder of Fulgent Genetics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Fulgent Genetics shares, with 4.19% of its total shares outstanding invested in 1.29M Fulgent Genetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools